Institute of Biomedical Sciences, Academia Sinica, Taipei 11529, Taiwan; Department of Chemistry, Saurashtra University, Rajkot, Gujarat, India.
Preclinical Pharmacology Core Laboratory, Molecular Pharmacology and Chemistry Program, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.
Bioorg Med Chem. 2010 Mar 15;18(6):2285-2299. doi: 10.1016/j.bmc.2010.01.061. Epub 2010 Feb 4.
A series of N-mustard-quinoline conjugates bearing a urea or hydrazinecarboxamide linker was synthesized for antitumor evaluation. The in vitro cytotoxicity studies revealed that compounds with hydrazinecarboxamide linkers were generally more cytotoxic than the corresponding urea counterparts in inhibiting human lymphoblastic leukemia and various solid tumor cell growths in culture. The therapeutic efficacy against human tumor xenografts in animal model was studied. It was shown that complete tumor remission in nude mice bearing human breast carcinoma MX-1 xenograft by 17a, i and 18c, d was achieved. In the present study, it was revealed that both linkers are able to lower the chemically reactive N-mustard pharmacophore and thus the newly synthesized conjugates possess a long half-life in rat plasma. Moreover, the new N-mustard derivatives are able to induce DNA cross-linking either by modified comet assay or by alkaline agarose gel shift assay.
一系列带有脲或肼基甲酰胺连接基的 N-芥喹啉缀合物被合成用于抗肿瘤评估。体外细胞毒性研究表明,带有肼基甲酰胺连接基的化合物在抑制人淋巴母细胞瘤和各种固体肿瘤细胞生长方面通常比相应的脲类化合物具有更高的细胞毒性。在动物模型中对人肿瘤异种移植物的治疗效果进行了研究。结果表明,化合物 17a、i 和 18c、d 可使荷有人乳腺癌 MX-1 异种移植物的裸鼠完全消退肿瘤。在本研究中,发现这两种连接基都能够降低化学活性的 N-芥类药效团,因此新合成的缀合物在大鼠血浆中有较长的半衰期。此外,新的 N-芥类衍生物能够通过改良彗星试验或碱性琼脂糖凝胶电泳迁移率变动试验诱导 DNA 交联。